Upcoming Cancer Conferences 2019 | Oncology Conferences Europe | Cancer Research ConferencesÂ | Cancer Therapy Conferences USA Asia Japan Australia Canada

Theme: Essential and progressive methods to treat cancer

Cancer Therapy 2019

Scientific Program

Renowned Speakers

Kathleen Kenney-Riley
Mercy College
USA

Jianyu Rao
University of California
USA

Robert W. Tygenhof
Integrative Medical Group of Irvine
USA

DanCMartin
Obstetrician-gynecologist in Memphis, Tennessee,
USA

Elliot M Levine
Obstetrician-gynecologist in Chicago, Illinois
USA

George Peery
Dean University of Texas USA
USA

Kwong-Kwok-Wong
University of Texas, USA
USA

Lei-Huo
The University of Texas
USA

Liane Deligdisch
Mount Sinai School of Medicine, USA,
USA

Linda Isaacs
Nutritional Research and Educational Foundation,
USA

Manjeet Rao
University of Texas
USA

Marike Gabrielson
Karolinska Institutet
USA

Megan McNeil
North Carolina State University
USA

Concepcion Diaz Arrastia
Rutgers Medical School in Piscataway, New Jersey
USA

Melissa Joyner
University of Texas
USA

Michaela Huynh
University of Texas
USA

Muthusamy Thangaraju
Georgia Regents University
USA

Nichola C Garbett
University of Louisville
USA

Gwyn Richardson
Gynecologic oncologist in Galveston, Texas,
USA

Joseph A Lucci
Gynaecologist in Houston, Texas
USA

Robin Farias Esiner
Ronald Reagan UCLA Medical Center, Santa Monica
USA

Samir A Farghaly
Obstetrics and Gynecology Cornell University USA
USA

Sherry Bradford
President, CSO, Co-Founder AccuTheranostics, Inc USA
USA

Adam Ostrzenski
Medical Director, Institute of Gynecology, USA
USA

Douglas N Brown
Massachusetts General Hospital, USA
USA

Felice L Gersh
Director Integrative Medical Group of Irvine, USA
USA

Muhammad A Jawad
Orlando Regional Medical Centerâ€™s Bariatric Program, USA
USA

Gregory M Christman
University of Florida, USA
USA

Michael Kleerekoper
University of Toledo, USA
USA

Rajeshwar Rao Tekmal
University of Texas Health Care, USA
USA

Michael L. Galloway
Wright State University, USA
USA

Nikolaos Zacharias
University of Texas Health Science Center, USA
USA

Michael Kamrava
Harvard Medical School, USA
USA

Seung-Cheol Lee
University of Pennsylvania USA
USA

Alain Charest
Harvard Medical School USA
USA

M. Ayub Hussain
New York Career Training Center, USA
USA

Ashok Srivastava
ClinFomatrix, USA
USA

Victor Frenkel
University of Maryland, USA
USA

Srinivas Pentyala
Stony Brook Medicine, USA
USA

Jim Zhai
Mayo Clinic,USA
USA

Rebecca Baergen
Weill Cornell Medicine, USA
USA

Anita Huttner
Yale University School of Medicine, USA
USA

John Michael Sauer
University of Arizona College of Medicine, USA
USA

Lixin Rui
University of Wisconsin-Madison, USA
USA

Jennifer Wu Hollings
Cancer Center-Medical University of South Carolina, USA
USA

Arpita Kulshrestha
Rosalind Franklin University of Medicine and Science, USA
USA

Qing Jiang
Purdue University, USA
USA

Jerome Check
Cooper Medical School of Rowan University,USA
USA

Jaime Tisnado
Virginia Commonwealth University, USA
USA

Jessy S Deshane
University of Alabama at Birmingham, USA
USA

Guan Chen
Medical College of Wisconsin, USA
USA

Brian W. Booth
Clemson University, USA
USA

Brian Keevil
University Hospital of South Manchester, UK
UK

Franco Maria Buonaguro
Istituto Nazionale Tumori, Italy
Italy

Donna Vine
University of Alberta, Canada
Canada

Taher H. Khalil
The Hormonal Disorders Specialty, UAE
UAE

Tamer Rizk
Sulaiman Alhabib Medical Group, Saudi Arabia
Saudi Arabia

Farhad Kamali
Newcastle University, UK
UK

Fredy Ariza Cadena
Universidad ICESI and Universidad del Valle, Colombia
Colombia

Magda Johanna Vandeloo
Hasselt University, Belgium, Belgium
Belgium

Magdalena Klink
Polish Academy of Sciences, Poland
Poland

Maria E Sales
University of Buenos Aires , Argentina
Argentina

Marta Recio Rodriguez
University of Madrid, Spain
Spain

Martin Kristensson
Visiopharm , Denmark
Denmark

Matin Burrow
DMB Diagnostics GmbH, Germany
Germany

Michael Friedrich
HELIOS Hospital, Germany
Germany

Michael Retsky
Harvard TH Chan School of Public Health, USA
USA

Pascalen A Cohen
University of Lyon, France
France

Alejandro Aldape Arellano
Spanish Fertility Society, Spain
Spain

Felix Day
Cambridge University, UK
UK

Ahmed Al Badr
Director King Fahad Medical City Saudi Arabia
Saudi Arabia

Ali Ahmad
NHS, UK
UK

Chain Kalinowski
Auckland university of technology, New Zealand
Newzealand

Stefan Schuster
SIMFO GmbH Bayreuth, Germany
Germany

Stefana Oana Purcaru
University of Medicine and Pharmacy of Craiova, Romania
Romania

Jiri Vachtenheim Charles
University in Prague Czech Republic
Czech Republic

Bo Yuan
Tokyo University of Pharmacy and Life Sciences, Japan
Japan

Hosam Al-QudahAlzahra Hospital Dubai UAE
Alzahra Hospital Dubai UAE
UAE

Hoda El-katerji
University of Ottawa, Canada
Canada

Zang-Hee Cho
Neuroscience Research Institute University of Suwon, South Korea
South Korea

Anna Ã„â€ wierz
Ludwik Rydygier Memorial Specialized Hospital, Poland
Poland

Leroy J. Lowe
Lancaster University, UK
UK

Katharina Pachmann
Transfusion Center Bayreuth, Germany
Germany

Amr Al-Haidari
Lund University,Sweden
Sweden

Christian Tiede
The University of Leeds, UK
UK

Devika Agarwal
Nottingham Trent University, UK
UK

N Y Gbandjaba
Institut Pasteur du Maroc, Morocco
Morocco

Feng Yan
Nanjing Medical University Cancer, China
China

Irina Velikyan
Uppsala University Hospital, Sweden
Sweden

Renata Dobrila-Dintinjana
Clinical Hospital Center Rijeka, Croatia
Croatia

Vladimir Zaichick
Medical Radiological Research Center, Russia
Russia

Katarina Jeremic
University of Belgrade, Serbia
Serbia

Oleg V. Gerasimenko
Cardiff University, UK
UK

Ozge Akbulut
Sabanci University, Turkey
Turkey

Mohammed Y Almaghrabi
Prince Faisal Cancer Center, Saudi Arabia
Saudi Arabia

Reinhard Buettner
University Hospital Cologne, Germany
Germany

Sonya Sergieva
Sofia Cancer Center, Sofia Bulgaria
Bulgaria

Eman Oweida
NMC Royal Hospital,UAE
UAE

Long-ping Wen
University of Science & Technology of China
China

Timor Al-Alshee
King Abdulaah Medical City Saudi Arabia
Saudi Arabia

Tarek Dufan
American Hospital Dubai UAE
UAE

Graciela Ghirardi
CÃƒÂ³rdoba Hospital, Argentina
Argentina

Jiangwen Zhang
University of Hong Kong Hong Kong
Hong Kong

Karol Sikora Proton
Partners International Limited UK
UK

Arjun Ghosh
Barts Health NHS Trust UK
UK

Adnan Yousif Rojeab
The London College UCK UK
UK

Qamar Bashir
University of Osl Norway
Norway

Chiara Mondello
Institute of Molecular Genetics Italy
Italy

Songul Cetik
Mardin Artuklu University, Turkey
Turkey

Thierry Virolle
Institut de Biologie Valrose France
France

Hu Jiancheng
National Cancer Centre Singapore Singapore
Singapore

Lei Xiao
Innovative Cellular Therapeutics, China
China

Cancer Therapy 2019

Conferenceseries llc Ltd heartily welcomes you all the supporters from all over the world to attend "38th Annual Conference on Advances in Cancer Research and Therapy" during November 11-12, 2019 in Madrid, Spain. This contains apt crucial concerts, Oral talks, Poster presentations and Exhibitions. The theme for the conference this year is “Essential and progress methods to cancer treatment” assurances and remaining scientific program introducing various familiar and thought provoking speakers. This offers a special way to modern the indications on latest progressions and researches with a complete approach to various areas of awareness. This conference tracks are planned in such a way to shield all the zones of studies convoluted with Cancer Therapy research and their effects on human health. The goal of this conference is to proposal a stage to all the scientists, doctors, medical professionals and business delegates who will absolutely improve the session by providing their opinions regarding recent inventions to all the attendees.

Cancer Therapy 2019 Conference main goal is to deliver ideal treatment methods and advance research studies information. Through focus on the anticipation, analysis of Cancer, as well as related Cancer Genetics, Pathophysiology, Epidemiology, ChemoTherapy, Clinical Reports, Cancer Biology etc. The shift in medicine and healthcare from administration of illness to endorsing wellness is a source in speaking the upstream initiated of illness and ensuring that all women have equal opportunities. Hence it is identical proper to convey together the professionals in the department from all over the sphere as we share involvements and knowledge and work together on reducing the risk and creating awareness of Cancer therapy.

Why to attend Cancer Therapy 2019?
Educative public with recent advances in Cancer Therapy from everywhere the world absorbed on cancer approximately modern advances in Cancer therapy, this is your only greatest chance to influence the chief gathering of contestants’. World-renowned orators, the best latest techniques, and the modern apprises in cancer research fields are trademarks of the conference.

The two day Cancer Therapy 2019 conference will be organized through a series of plenary sessions where attendees can avail the opportunity to both networks and perceive leaders from the global academics and corporate Cancer Therapy and Research Communities.

Target Audience:

Directors/Managers

President & Vice Presidents/ Directors

Doctors

Research Scholars

Scientists

Radiation oncology research faculty

Radiologist

Oncologist

Therapist

Breast Care Nurse

Surgeon

Cancer Surgeons

Pathologists

Brand Manufacturers/ Marketers of Consumer Products

Marketing, Advertising and Promotion Agency Executives

Business Entrepreneurs

Training Institutes

Nurse Practitioners/Nurses

Healthcare Faculty

Cancer Associations and Societies

Cancer Therapy:

The treatment of cancer will be done in various ways. Removal of tumours through surgery has done in earlier stage. Later on therapies like hormone therapy and radiation therapy were developed. The development in cancer treatment process is to increase the survivability and quality of life.

Track 1: Cancer Therapy:

The various treatment methods which are used to cure cancer are known as cancer therapy. Methods should be different and it depends upon the location of the tumor and the stage of cancer. Still, research is going on to develop some other methods to cure cancer. The main aim of the cancer therapy is to free from pain and cancer symptoms. In present custom, the tenure "chemotherapy" regularly denotes to cytotoxic drugs which disturb fast isolating cells in general, in difference with targeted therapy. Furthermost forms of chemotherapy mark all swiftly separating cells and are not precise to cancer cells, while some grade of specificity may come from the incapability of many cancer cells to repair DNA damage.

• Radiation therapy

• Chemotherapy

• Targeted therapies

• Immunotherapy

• Hormonal therapy

• Cancer immune therapy and vaccines

• Electrochemotherapy

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 09-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 03-04 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

European Oncology Societies: European Society for Gene and Cell Therapy, International Society for Stem Cell Research (ISSCR), UK Oncology Nursing Children’s Cancer and Leukemia Group Society, European Society of Oncologic Imaging, European Association for Cancer Research

USA Oncology Societies: American Cancer Society (ACS), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), American Society of Clinical Oncology (ASCO)

Asian Oncology Societies: Asian Oncology Nursing Society (AONS), Asian Society of Gynecologic Oncology (ASGO), Asian Society of Head & Neck Oncology (ASHNO), Federation of Asian Organizations for Radiation Oncology (ARO)

Track 2: Cancer Research:

Cancer research categories since epidemiology, molecular bioscience to the presentation of medical hearings to assess and relate presentations of the different cancer behaviours. These presentations contain surgery, radiation therapy, chemotherapy, hormone therapy, immune therapy and combined treatment modalities such as chemo-radiotherapy. Cancer research contains a multiplicity of forms and interdisciplinary ranges of research. Researchers elaborate in cancer investigation may be skilled in spaces such as chemistry, biochemistry, molecular biology, physiology, epidemiology, and biomedical engineering. Research accomplished on an initial level is referred to as basic research and is envisioned to explain scientific ideologies and appliances. Translational research objects to explain appliances of cancer development and development and renovate simple scientific results into ideas that can be appropriate to the behaviour and inhibition of cancer. Clinical research is devoted to the progress of pharmaceuticals, surgical procedures, and medical technologies for the ultimate action of patients.

Cause and development of cancer
Genes involved in cancer
Reoviridae
Dominance of cancer research
Biotechnology Research

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 4th International Conference on Nanomedicine and Nanomaterials | June 19-20, 2019| Dublin, Ireland; 2nd International Conference on Cell and Gene Therapy | October 3-4, 2019 | Melbourne, Australia; 2nd International Conference on Molecular Biology and Stem Cells | June 6-7, 2019| London, UK; 3rd World Congress and Expo On Cell & Stem Cell Research | June 10-11, 2019| Edinburgh, Scotland; 4th World Congress on Cell Science, Stem Cell Research and Regenerative Medicine | September 19-20, 2019| Paris, France

Track 3: Cancer Biology:

The science which deals with cancer cells are known as Cancer Biology. The main aim of cancer biology is to understand the sudden change in cells and how it is developed and varied from normal cells to cancer cells. These manners of research in cancer biology have laid a path to prevention, diagnosis and treatment. Tumours are considered by genomic and epigenetic uncertainty that modifies the purposes of various altered particles and systems in a solo cell as well as varying the communications with the native situation. Cancer systems biology attitudes, therefore, are grounded on the custom of computational and precise systems to translate the complication in tumor creation as well as cancer heterogeneity.

• Cancer gene discovery

• Cancer models

• Metabolism

• Growth control

• Cancer stem cells

• Oncology

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 4: Cancer Metastasis:

The process of wandering cancer cells from one place to another place through blood is known as cancer metastasis. Finally, cancer cells stops in a small blood vessel walls and move to the surrounding tissues. Cancer cells grows in that tissues until a tumor formation takes place.in this process some cancer cells will die at some point. Depends on the type of cancer there are various metastasis sites. This metastasis doesn’t cause symptoms. Treatment for metastatic cancer will leads to long life.

• Cancer cells growth

• Cell transplantation through lymph

• Systemic metastasis

• Cell fusion

• Tumor cells grown

• Clinical and Experimental Metastasis

Related Conferences:

Track 5: Organ Specific Cancer:

In human body various body organs will be affected to cancer cells. Depends on the organ of the body where cancer exists, various cancers are present. The symptoms, pain and treatment are different from one organ to another. Irrespective of age, it will occur in children too. There are various treatment techniques for cancer, depends on the location of the organ. The abnormal increase in the number of cells in the body and formation of tumor takes place in an organ will lead an organ cancer. There are various types of organ cancers.

• Breast Cancer

• Brain cancer

• Lung Cancer

• Liver cancer

• Leukaemia

• Paediatric cancer

• Gallbladder cancer

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 6: Radiation Therapy:

It is one of the cancer treatment techniques. In Radiation therapy by the usage of ionizing radiation the cancer cells will be damaged. In this process of radiation therapy some normal cells also get effected. Mostly, normal cells can recover from these effects and work properly. The main aim of radiation therapy is to kill cancer cells as much as possible by damaging their DNA. Meanwhile, in this process some surrounding healthy organs also effects. Radiation therapy does depend on various factors like type of cancer and sensitivity and some other. This radiation therapy can also be used as a part of adjuvant therapy.

• Distinguish the radio sensitivity of a particular tumor.

• Damaging the DNA of cancerous cells

• Three dimensional dose distribution using dosimetry technique\3-dimensional confirmation radiation therapy

• Radio surgery

• Intensity-modulated radiation therapy.

Related Conferences:

Track 7: Chemotherapy:

Basically, chemotherapy means usage of any variety of drug to cure any disease. But, mostly it says that one type of cancer treatment methods. In chemotherapy large variety of drugs are used for the treatment of cancer. A large number of variety drugs are used in chemotherapy to kill more cancer drugs. These drugs can be transferred through blood cells or directly to specific cancer site. By using surgery and radiation therapy we can damage or remove cancer cells but chemotherapy can work throughout the body. Chemotherapy can be used alone or with other treatments.

• Combination chemotherapy

• Neoadjuvant

• Adjuvant chemotherapy

• Chemotherapy regimens

• Cytoxic chemotherapy

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 8: Targeted therapies:

Targeted therapy is a type of cancer treatment which uses drugs and some other substances to find out and affect the specific cancer cells. By focusing on specific genes, proteins or the tissue environment the targeted therapies work. It means focus and act only on that particular molecular, which is associated with cancer. This targeted therapy helps the immune system to destroy cancer cells, stop cancer cells from growing. There are various types in targeted therapies like small molecule drugs and monoclonal antibodies.

• Molecular medicine

• Targeted therapy for breast cancer

• Targeted therapy for lung cancer

• Targeted therapy for colorectal cancer

• Damages the cancer cells in targeted place where cancer cells are present.

Related Conferences:

Track 9: Immunotherapy:

Immunotherapy it is also known as biologic therapy. It is one of the methods of various cancer treatments. This immunotherapy increases the natural defence system in our body to fight against cancer cells. It works by stopping the flow of cancer cells and it helps in stimulating the immune system to destroy tumours. There are different types of immunotherapies.

• Cellular immunotherapy.

• Combination immunotherapy.

• Cytokine therapy.

• Active immunotherapy.

• Non-specific active immunotherapy

• Specific immunotherapy

• Cancer and Autoimmunity

Related Conferences:

Track 10: Cancer gene therapy:

Genes are used to treat illness. Gene therapy works by getting genes into cancer cells, which is a very difficult task. To overcome this difficulty still, research is going on to develop different types of gene therapy to cure cancer. Basically, the gene is carried to cancer cell through a carrier called vectors. Common type of carrier used in gene therapy is viruses so that they can easily enter the cells and deliver genetic material. Genes play a vital role in cell as; they are only responsible for cell growth, function and divide. The main aim of gene therapy is to replace abnormal or absent genes with healthy one that make cell to produce useful proteins. Finally, it can say that gene therapy is for cell survival.

• Encourages cell to function properly.

• Repair damaged genes.

• Stops cell multiplying.

Related Conferences:

Track 11: Cancer stem cell therapy:

Cells which are present in tumor and have the capabilities of self-renewing and ability to give rise to many cells are known as cancer stem cells. Cancer stem cell model also known as hierarchical model process. Cellular therapies are a part of complimentary treatment regimens.

• Stem cell mutation

• Cancer stem cell and immunology model

• Stochastic model

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 12: Molecular targeted therapy:

It is an example of targeted therapy. By using drugs or some other substance target specific molecules which are involved with the growth and spread of cancer. Drugs which are used in molecular targeted therapy are interfering only with molecular abnormality which drives cancer growth. Through this molecular targeted therapy only cancer cells will damage. It is better to compare with other treatments because only little harms to normal cells which results in side effects. Molecular targeted therapy is the best way to customize cancer treatment.

• Small molecule drug conjugates.

• Quality of life

• Few side effects

• Less harm to normal cells.

Related Conferences:

Track 13: Hormonal therapy:

It is also known as hormone withdrawal therapy, hormone manipulation or endocrine therapy. Hormonal therapy is using of hormones in medical treatment to stop or remove the cancerous growth cells. Hormones which are used in the treatment process are prepared in laboratories. Basically, natural hormones are produced by glands or organs in the body. There are various types of hormonal therapies.

• Destroy hormone producing cells.

• Hormonal drug therapy.

• Hormone replacement therapy.

• Growth hormone therapy.

• Antihormone therapy

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 14: Surgical oncology:

By using surgery method treating cancer is known as surgical oncology. This surgery oncology can be used alone or with other treatment methods also. For some patients surgery is the only way to treat cancer. Most of the people surgery is used along with other treatment techniques. Through surgery cancer tumours can be removed. Only few types of cancers can be treated with surgery.

• Minimally invasive cancer surgery

• Natural Orifice Trans luminal Endoscopic Surgery

• Sentinel node biopsy

• Robotic surgery

• Reconstructive Surgery

• Cancer Biopsy

Related Conferences:

Track 15: Cancer Imaging:

Cancer imaging is a term used to research and diagnose the cancer. It plays an important role in detection. Not only in detection. Imaging is also important in analysing the stage of cancer. Originally cancer imaging is used to detect and stage the disease. Now, it is used to assist with surgery and radiotherapy. Through this imaging analysis only the treatment methods for cancer should be possible because detection is possible and the stage of the cancer will be known.

• X-ray imaging

• Computed Tomography (CT) Scans

• Molecular and Nuclear imaging

• Magnetic resonance imaging

• Image guided surgery

• Photoacoustic imaging

Related Conferences:

Track 16: Cancer Diagnosis and Screening:

The main aim of cancer diagnosis and screening is to detect at early stage and prolong the human life. Imaging plays a vital role in diagnosis. Screening is to find out the tumours at very early stage so that they can be curable. Diagnosis technologies are of different from screening technologies. There are various screening tests depends on the organ. Through this cancer diagnosis and cancer screening the quality of human life will increase.

• Mammography

• Colonoscopy

• Sigmoidoscopy

• Stool DNA tests

• Fecal occult blood test

• Pap test and human papillomavirus (HPV) testing

• Low-dose helical computed tomography

• Alpha-fetoprotein blood test

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 17: Cancer Nanotechnology:

Many examinations have shown that mutually tissue and cell distribution reviews of anticancer drugs can be measured by their entrapment in nanoparticles. The rationale behind this approach is to growth antitumor efficacy, while dropping systemic side-effects. This evaluation offers an update of tumor targeting with straight or long-circulating nanoparticles. The in vivo fate of these systems, later intravascular or tumoral administration, is discussed, as well as the tool involved in tumor regression. Nanoparticles are also of benefit for the choosy distribution of oligonucleotides to tumor cells. Besides, converted types of nanoparticles disclosed some fascinating volume to reverse MDR, which is a major problem in chemotherapy. The chief experimentations, targeting to deck nanoparticles with molecular ligand for 'active' targeting of cancerous cells, are also discussed here. The latest part of this evaluation emphasis on the application of nanoparticles in imaging for cancer diagnosis.

• Iodine nanoparticle radiotherapy

• Magnetic Hyperthermia

• pH-activated nanoparticles

• Mitochondrial redox homeostasis

Related Conferences:

Track 18: Cancer Therapeutics:

It includes an forever-cumulative array of tools at the clearance of clinicians in their behaviour of this illness. Though, cancer is a hard enemy in this clash, and present actions, which classically contain radiotherapy, chemotherapy and surgery, are not frequently sufficient to free the persistent of his or her cancer. Cancer cells can develop unaffected to the behaviours engaged at them, and overwhelming this drug conflict is an significant study effort.

• Molecular cancer therapeutics

• Therapeutic oncology

• Small molecule therapeutic

• Large molecule therapeutic

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 19: Cancer Bioinformatics :

Cancer Bioinformatics is a serious and significant portion of the schemes clinical remedy in cancer and the main tool and methodology to bring available the examinations of cancer in systems clinical medicine. Genome Medicine and Journal of Clinical Bioinformatics to momentous the submission of cancer Bioinformatics for the growth of Bioinformatics systems, system biomarkers and accuracy treatment. The Sequence efforts on fresh advances in cancer Bioinformatics and computational systems biology to discover the possibility of clinical requests and advance the consequences of patients with cancer.

• Structural Bioinformatics

• Proteomics

• Epigenetics

• Next generation sequencing

• Dynamic networks

Related Conferences:

Track 20: Cancer Pharmacology:

Investigation determinations in sarcoma pharmacology take account of trainings of the simple instruments of indication transduction related with cell multiplying and apoptosis, the contrivances of achievement of anti-neoplastic agents, the scheme and finding of original drugs, simple contrivances of DNA repair and DNA impairment acceptance and the progress of fresh plans for gene therapy. Importance is hired on the account and classification of elementary signing machines that create the marks of molecules used for cancer therapy and DNA damage and renovation apparatuses that pay to anti-neoplastic drug conflict. The rule of tyrosine kinases, treating of proto-oncogenes, parameter of minor GTPases and their effectors, cell-cycle-specific kinases and DNA repair gene products are actuality studied as possible marks or to improve the efficiency of present chemotherapeutic means. The part of growing elements in the movement of solid and hematopoietic tumors is existence studied; innovative receptors and signal transduction paths are being recognized in usual and malicious tissues.

• Design and discovery of new drugs

• Cancer Vaccines

• Side effects

• Precision Oncology

• Clinical Trial Information

• Clinical Research

Related Conferences:

38th Annual Conference on Advances in Cancer Research and Therapy | November 11-12, 2019 | Madrid, Spain; 37th World Cancer Conference | October 9-10, 2019 | Dublin, Ireland; 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology | July 25-27, 2019 | London, UK; 9th Cancer Diagnostics & Treatment Conference |Nov 11-12, 2019| Frankfurt, UK; 2nd World Congress on Breast Cancer, Gynecology and Women Health Milan, Italy; 16th International Conference on Oncology Nursing and Cancer Care | April 15-16, 2019| Frankfurt, Germany; 2nd Global Congress on Cancer Science and Therapy | July 22-23, 2019| Brussels, Belgium; Cancer Genetics and Epigenetics Gordon Research Conference |Apr 07 - 12, 2019| Lucca, Tuscany; 2nd Global Conference on Cancer Research & Clinical Trials |June 3-4 2019| Rome, Italy; World Congress on Thyroid Cancer 3.5, Rome, Italy; 11th World Hematology and Oncology Congress |July 24-25| Rome, Italy; 5th International Conference on Oncology and Research |July 25-26| Rome, Italy; 25th Global Meet on Cancer Research & Oncology |May 20-21| Rome, Italy; 27th World Conference on Clinical and Medical Oncology |July 25-26| Rome, Italy; 2nd World Congress on Breast Cancer |August 19-20| Dublin, Ireland; 26th International Conference on Cancer and Oncology |November 11-12| London, UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Track 21: Cancer Prevention and Management:

Cancer prevention is better than cancer cure. Cancer prevention is the exercise of enchanting energetic events to drop the occurrence of cancer and death. The repetition of prevention is in need of upon mutually discrete exertions to increase life and strive for protective screening and socioeconomic or community rule linked to cancer prevention. Globalized cancer prevention is observed as a serious independent due to its applicability to great general public, sinking extended tenure things of cancer by sponsoring active health follows and behaviours, and its apparent cost-effectiveness and capability for all socioeconomic classes.

• Diet and Lifestyle

• Chemoprevention

• Risk-reducing surgery

• Infections

• Immunosuppressive Medicines After Organ Transplant

• Physical Activity

• Obesity

Related Conferences:

UK; World Congress on Cancer Science and Therapy |September 16-17| Scotland, UK; 2nd International conference on Cell and Gene Therapy Milan, Italy

Cancer Therapy 2019 will be one of the World’s greatest platforms for Oncologists, radiologists, pathologists, diagnostic councillors, Clinical Researchers, medical professionals, students, non-invasive surgeons, medical device manufacturers and marketing agencies to discover the novel technologies and adapt them for a better potential future.

Now, with the theme ‘Essential and Progress Methods to Cancer Treatment’ we would be happy to invite all speakers/delegates at this splendid event to witness world’s best stage on Oncology and Cancer

These occasions are identified for being a collaborative forum to exchange thoughts and network through symposium, panel discussions, poster sessions, and the exhibition.

Target audience

Principle Investigators and Directors, Oncologists, Radiologists, Pathologists, Clinical Researchers, Clinical Coordinators, Scientists, Nurse Practitioners, Group Leaders, Medical Imaging and Clinical Research Association and Societies Professionals, Bio-Medical Company professionals, Young Researchers, Academic professors and students, Medical Imaging Associations and Societies, Clinical Research Associations and Societies, Business Magnates.

Market Analysis Report

The global cancer diagnostics market dimension was esteemed at USD 144. 4 billion in 2018 and is predictable to catalogue a CAGR of 7.0% over the prediction era. Increasing frequency of oncologic cases, continuous technical progressions in diagnostics and growing mandate for operative screening trials are selected of the major aspects prompting claim for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors estimated to boost market advance during the calculation period.

Cancer Research is one of the foremost sources of expiries across the domain and occurrence of the illness has been escalating at an alarming rate. Therefore, healthcare specialists are concentrating on advance of operative diagnostic and treatment results to check occurrence level. Initial recognition advances the accomplishment rate of treatment procedures. As an outcome, healthcare activities and market players, through numerous awareness packages, are promoting routine inspections.

Though several transmission measures, such as lab tests, imaging, and endoscopy, enable disease detection at an early stage, there are certain risk causes stood by medical imaging. These comprise extreme radiation exposure and management of bright and barium contrast broadcasting in imaging and endoscopic events, which source a number of adversarial belongings such as nausea and diarrhoea. In addition, the cost involved in performance analysis is comparatively high. Thus, the unpleasant belongings related with imaging solutions, coupled with the great cost of analysis, are predicted to delay market growth.

Cancer Diagnostics

The Breast Cancer section taken the major part of 14.0% in 2018 in the cancer diagnostics market. Mammography is the maximum communal and prevalent transmission assessment engaged for breast tumor screening. According to the United States Preventive Services Task Force (USPSTF), women aged amongst 50 and 74 years are at an advanced danger of evolving breast cancer. Thus, USPSTF commends women above 40 years of age to endure mammography every two years.

Description: Global cancer diagnostics market

In count, several administrations such as the National Breast Cancer Foundation, Inc. are undertaking creativities to blowout alertness about breast cancer, profits of early recognition, and obtainable treatment choices. Accumulative awareness of the people, attached with campaigns promoting routine mammography, is resulting in high demand for imaging solutions in breast cancer screening.

On the other hand, surging consumption of tobacco and alcohol is ensuing in amplified dominance of tumor in the liver and kidney. Thus, petition for liver and kidney Cancer Screening is anticipated to rise significantly in the coming years.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 11-12, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View